Literature DB >> 26032661

Hypoxic hepatitis in survivors of out-of-hospital cardiac arrest.

Sang Hoon Oh1, Han Joon Kim2, Kyu Nam Park1, Soo Hyun Kim1, Young Min Kim1, Chun Song Youn1, Jee Yong Lim1.   

Abstract

INTRODUCTION: Hypoxic hepatitis (HH) is commonly observed in out-of-hospital cardiac arrest (OHCA) survivors. The objective of this study was to investigate the incidence, clinical courses, and outcomes of as well as predisposing factors for HH in OHCA survivors.
METHODS: The study was based on a registry of cardiac arrest cases from 2009 to 2012 at a tertiary university hospital. We assessed patients' serum aminotransferase levels on return of spontaneous circulation (ROSC) and at 6, 12, 24, 48, and 72 hours postarrest. Hypoxic hepatitis was defined as a rapid increase in serum aminotransferase that reached at least 20 times the upper limit of normal. The patients were classified into 2 groups: the HH group and the non-HH group; we then analyzed the outcomes of the HH group. Independent predisposing factors to HH in this cohort were identified.
RESULTS: Of a total of 535 OHCA cases, 148 patients were enrolled in this study. Hypoxic hepatitis was identified in 13.5% (n = 20) of them. Serum aminotransferase rapidly increased in the first day after return of spontaneous circulation. Of the patients who developed HH, 5 (25%) survived to hospital discharge, and none of these individuals had good neurologic outcomes (Glasgow-Pittsburgh cerebral performance categories 1 and 2). Using multivariate logistic regression, we found that the no flow time was independent predictors of HH (odds ratio, 1.085 [95% confidence interval, 1.027-1.146]; P = .003).
CONCLUSIONS: Hypoxic hepatitis occurred frequently in survivors of OHCA. The no flow time was an independent risk factor for HH, which was significantly related to death and poor neurologic outcomes.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26032661     DOI: 10.1016/j.ajem.2015.05.008

Source DB:  PubMed          Journal:  Am J Emerg Med        ISSN: 0735-6757            Impact factor:   2.469


  6 in total

Review 1.  [Hepatic dysfunction in patients with cardiogenic shock].

Authors:  Philipp Kasper; Frank Tacke; Hans-Michael Steffen; Guido Michels
Journal:  Med Klin Intensivmed Notfmed       Date:  2019-09-19       Impact factor: 0.840

2.  Exploring donor demographics effects on hepatocyte yield and viability: Results of whole human liver isolation from one center.

Authors:  Sharon Geerts; Sinan Ozer; Chris Chu; Bryan C Fuchs; Kenneth K Tanabe; Heidi Yeh; Korkut Uygun
Journal:  Technology (Singap World Sci)       Date:  2019-04-26

3.  Acute liver dysfunction after cardiac arrest.

Authors:  Enrica Iesu; Federico Franchi; Federica Zama Cavicchi; Selene Pozzebon; Vito Fontana; Manuel Mendoza; Leda Nobile; Sabino Scolletta; Jean-Louis Vincent; Jacques Creteur; Fabio Silvio Taccone
Journal:  PLoS One       Date:  2018-11-05       Impact factor: 3.240

4.  Targeted Temperature Management as a Cause of Liver Injury.

Authors:  Hassan Azhari; Mark G Swain
Journal:  Hepatol Commun       Date:  2019-08-07

Review 5.  Post-resuscitation shock: recent advances in pathophysiology and treatment.

Authors:  Mathieu Jozwiak; Wulfran Bougouin; Guillaume Geri; David Grimaldi; Alain Cariou
Journal:  Ann Intensive Care       Date:  2020-12-14       Impact factor: 6.925

6.  The Impact of Hypoxic Hepatitis on Clinical Outcomes after Extracorporeal Cardiopulmonary Resuscitation.

Authors:  Yun Im Lee; Min Goo Kang; Ryoung-Eun Ko; Taek Kyu Park; Chi Ryang Chung; Yang Hyun Cho; Kyeongman Jeon; Gee Young Suh; Jeong Hoon Yang
Journal:  J Clin Med       Date:  2020-09-16       Impact factor: 4.241

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.